Company intelligence
Thalocan Research Innovations
Support for teams using clinical endpoint measures in immuno-dermatology clinical studies.
Business Consulting and Services
Indianapolis, US
13 employees
Founded 2022
4 public signals
About Thalocan Research Innovations
Thalocan Research Innovations was created to address challenges in clinical trial endpoint management in the immuno-dermatology therapeutic area. With deep experience supporting clinical trial communications and best practices gathered over 18 years, TRI has a focus on process improvement around disease state and endpoint assessment instruction for clinical studies.
Verified activity
Signals from Thalocan Research Innovations
4 published signals
Presence & Recognition
Thalocan Research Innovations Senior Director of Business Strategy Teresa DeHaemer chats with Regan Wann about TRI's rapid growth as a fairly young company.
Reported by Thalocan Research Innovations
Partnerships
Thalocan Research Innovations is grateful for its clients and looking forward to continuing partnerships.
Reported by Teresa DeHaemer
Presence & Recognition
Thalocan Research Innovations CEO Eric Zudak will be in attendance at the Science of Skin Summit in Austin, Texas, in just over two weeks.
Reported by Thalocan Research Innovations
Partnerships
Thalocan Research Innovations partnered with Dr. Arash Mostaghimi, MD, MPA, MPH on four Alopecia trainings including SALT, BELA, BETA, and iAlfa during September
Reported by Thalocan Research Innovations